Declaración del Comité Consultivo de Inmunizaciones de la Sociedad Chilena de Infectología respecto a la vacuna antivirus papiloma humano: Septiembre 2008

• Katia Abarca V ^[1] ; M Teresa Valenzuela B ^[2] ; Rodrigo Vergara F ^[3] ; Vivian Luchsinger F ^[4] ; Alma Muñoz M ^[6] ; Jorge Jiménez de la J ^[1] ; Erna Ripoll M ^[5] ; Miguel O'Ryan G ^[4]
  1. [1] Pontificia Universidad Católica de Chile

     Pontificia Universidad Católica de Chile

     Santiago, Chile

     
  2. [2] Universidad de Los Andes

     Universidad de Los Andes

     Colombia

     
  3. [3] Universidad de Valparaíso

     Universidad de Valparaíso

     Valparaíso, Chile

     
  4. [4] Universidad de Chile

     Universidad de Chile

     Santiago, Chile

     
  5. [5] Hospital Carlos Van Buren

     Hospital Carlos Van Buren

     Valparaíso, Chile

     
  6. [6] Centro para Vacunas en Desarrollo

  Mostrar afiliaciones +
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 136, Nº. 11, 2008, págs. 1485-1492
• Idioma: español
• Títulos paralelos:
  • Human papillomavirus vaccine: Statement of the Advisory Committee of Immunizations on Behalf of the Chilean Infectious Diseases Society. September 2008
• Enlaces
  • Texto completo
• Resumen

  • This article briefly reviews the epidemiology of human papillomavirus (HPV) infection and associated diseases globally and in Chile, and the scientific ínformatíon of the licensed HPV vaccines: Gardasil® and Cervarix®. Considering the available information, the Advisory Committee on Immunizations of the Chilean Society of Infectious Diseases recommends vaccination of teenage girls, ideally before initiating sexual actívíty, Le. approximately at the age of 12 to 13 years and vaccination of women of any age if they have not started sexual activity. If women are vaccinated after initiating sexual activity, they should be informed of the lower efficacy of immunization if HPV infection has occurred. Education on responsible sexuality and sexually transmitted diseases should be maintained as a priority. Vaccination should be highly considered for inclusion in the National Immunization Program.